These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12013330)

  • 21. Atypical pathogens and challenges in community-acquired pneumonia.
    Thibodeau KP; Viera AJ
    Am Fam Physician; 2004 Apr; 69(7):1699-706. PubMed ID: 15086042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of community-acquired lower respiratory tract infections during pregnancy.
    Lim WS; Macfarlane JT; Colthorpe CL
    Am J Respir Med; 2003; 2(3):221-33. PubMed ID: 14720004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults--Swedish Society of Infectious Diseases 2012.
    Spindler C; Strålin K; Eriksson L; Hjerdt-Goscinski G; Holmberg H; Lidman C; Nilsson A; Ortqvist A; Hedlund J;
    Scand J Infect Dis; 2012 Dec; 44(12):885-902. PubMed ID: 22830356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of community-acquired pneumonia.
    Bartlett J
    Chemotherapy; 2000; 46 Suppl 1():24-31. PubMed ID: 10810210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.
    Patel T; Pearl J; Williams J; Haverstock D; Church D
    Respir Med; 2000 Feb; 94(2):97-105. PubMed ID: 10714413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-Acquired Pneumonia in Children.
    Leung AKC; Wong AHC; Hon KL
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):136-144. PubMed ID: 29932038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
    Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL
    Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-acquired pneumonia in children.
    Stuckey-Schrock K; Hayes BL; George CM
    Am Fam Physician; 2012 Oct; 86(7):661-7. PubMed ID: 23062094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community-acquired pneumonia.
    Ong KC; Eng P
    Singapore Med J; 1995 Oct; 36(5):539-44. PubMed ID: 8882544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What is new in the treatment of community-acquired pneumonia?].
    Welte T; Marre R; Suttorp N;
    Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient treatment of pneumonia.
    Grant CC; Ingram RJ
    N Z Med J; 2000 Feb; 113(1104):58-62. PubMed ID: 10777227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of community-acquired pneumonia].
    Gillissen A; Ewig S
    Med Klin (Munich); 2000 Mar; 95(3):169-70. PubMed ID: 10771565
    [No Abstract]   [Full Text] [Related]  

  • 36. Pneumonia. Patient profiles, choice of empiric therapy, and the place of third-generation cephalosporins.
    Leedom JM
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):57-65. PubMed ID: 1730186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The problems of treating atypical pneumonia.
    Schlick W
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():111-20. PubMed ID: 8478302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia].
    Fujiki R; Rikimaru T; Aizawa H; Kawayama T
    Jpn J Antibiot; 2003 Dec; 56(6):712-8. PubMed ID: 15007880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.